Honorary Clinical Senior Lecturer. Nervous Systems Disorders Speciality Lead. Neurology Long Term Conditions Clinical Lead

Transcription

1 Curriculum vitae PERSONAL INFORMATION Waqar Rashid WORK EXPERIENCE November 2008 Present Consultant in Neurology Brighton and Sussex University Hospitals NHS Trust, Hurstwood Park Neurological Centre, Haywards Heath and Royal Sussex County Hospital, Brighton, Sussex (United Kingdom) 2010 Present Honorary Clinical Senior Lecturer Brighton and Sussex Medical School, University of Sussex (United Kingdom) June 2011 January 2013 Nervous Systems Disorders Speciality Lead Surrey and Sussex Comprehensive Local Research Network (CLRN) (United Kingdom) Substantive consultant post in regional neuroscience centre for Sussex. Undertaking general clinical neurology and also subspecialty lead in neuroinflammatory disorders February 2014 Present Neurology Long Term Conditions Clinical Lead South East Coast Strategic Clinical Network, Mental Health, NHS England Dementia and Neurological Conditions Domain (United Kingdom) Responsible for development of models of neurological care and liaison with regional CCGs and NHS England within Kent, Surrey and Sussex. May 2008 November 2008 Educational supervisor: Dr M Matharu National Hospital for Neurology & Neurosurgery (United Kingdom) Tertiary referral centre for UK. Duties include: management of acute and planned admissions, participation in clinical, radiological and pathological meetings, general neurology clinics and specialist clinics in headache, muscle and nerve disease and cognitive disorders. February 2007 January 2008 Educational Supervisor: Dr A Al-Chalabi King s College Hospital NHS Trust, Denmark Hill, London SE5 (United Kingdom) Regional centre for south east London and Kent. Specialist clinics in motor nerve disorders, peripheral nerve and movement disorders as well as general clinics and participation in acute thrombolysis and acute TIA out of hours service February 2006 January 2007 Educational Supervisor: Dr P Hughes Hurstwood Park Neurological Centre, Haywards Heath, Sussex (United Kingdom) Regional centre for Sussex. General neurology commitments and participation in regional out of hours on call service November 2005 January 2006 Educational Supervisor: Dr D Playford National Hospital for Neurology & Neurosurgery (United Kingdom) Specialist clinics in neurorehabilitation, spasticity and baclofen pump management February 2008 April 2008 Locum Consultant in Neurology Brighton and Sussex University Hospitals NHS Trust, Hurstwood Park Neurological Centre, Haywards Heath and Royal Sussex County Hospital, Brighton, Sussex (United Kingdom) Three month locum with London Deanery. Undertaking full consultant role with three general clinics, 7/6/17 European Union, Page 1 / 7

2 ward referrals, on call and ward rounds in regional neuroscience centre in Sussex August 2005 November 2005 Locum Appointment for Training (LAT) Specialist Registrar in Neurology London Deanery, Charing Cross Hospital (United Kingdom) Educational Supervisor: Prof C Kennard August 2005 August 2005 Locum Appointment for Service (LAS) Specialist Registrar in Neurology Leicester General Hospital (United Kingdom) Educational Supervisor: Dr R Abbott April 2005 August 2005 Locum Appointment for Service (LAS) Specialist Registrar in Neurology City Hospital, Birmingham (United Kingdom) Educational Supervisor: Dr S Sturman July 2001 February 2005 Dept of Neuroinflammation, Institute of Neurology, Queen Square, London Clinical Research Fellow in Neurology (United Kingdom) Regular neuroinflammatory specialist clinic experience throughout June 2000 June 2001 Locum Appointment for Training (LAT) Specialist Registrar in Neurology Northern Deanery, Newcastle General Hospital (United Kingdom) Educational Supervisor: Dr T Walls EDUCATION AND TRAINING October 2005 PhD (Clinical Neurological Studies) March 2000 MRCP (UK) 1990 June 1996 MBBS Charing Cross & Westminster Medical School, University of London (United Kingdom) BSc in the History of Medicine, Upper 2nd class Honours The Wellcome Institute, University of London ADDITIONAL INFORMATION Expertise Neurology I have extensive neurological clinical experience at all levels of seniority and was appointed as a substantive consultant in I have set up a regional specialist MS service including tertiary referral treatment and multi-disciplinary clinics, an infusion treatment service, made available locally several clinical drug trials and liaised with commissioning management regarding service redesign and expansion. From 2010 I have participated in regional and national managerial roles including: (1) ABN neuroinflammatory committee; (2) Nervous systems disorders CLRN lead for Surrey and Sussex and (3) Neurological Lead for Long Term Conditions for the South East Coast Strategic Clinical Network (see Managerial roles above). In recognition of the work I have done within Sussex as a consultant I have been awarded two clinical 7/6/17 European Union, Page 2 / 7

3 excellence award merit points in Teaching Co-written an international e-learning module on neurological complications of rheumatological disorders as part of the Joint Neurosciences Council e-brain project. Lectures to third and fourth year Brighton and Sussex Medical School (BSMS) students on neuroinflammatory disorders several times per year and bedside clinical neurology teaching to fourth year BSMS students. Supervision of specialist registrar clinics. Neuroinflammatory disorders teaching on general practitioner training days 2010 and Taught on MRCP PACES training days. Attended TIPS course for clinical teachers in Publications Reviewer of research papers Reviewed original papers for possible publication for the Journal of Neurology, Neurosurgery and Psychiatry, the Journal of Magnetic Resonance Imaging and Multiple Sclerosis Journal in the last three years. Comprehensive Local Research Network (CLRN) regional lead for Nervous System Disorders in Surrey and Sussex. Formally appointed 22/6/11 having been interim lead since September Responsible for liaising with other regional leads and the pharmaceutical industry at national level in the coordination and development of both academic and clinical trials research for neurological disorders. Undertaking a number of clinical drug trials in clinical neurology. Tenure completed in January PhD Thesis: The Investigation of pathogenesis in multiple sclerosis using quantitative magnetic resonance imaging parameters. PhD awarded in Clinical Neurological Sciences by The University of London, Oct Supervisors: Prof DH Miller, Prof G Barker. PhD thesis investigating the role of quantitative MR imaging (cord atrophy, diffusion and perfusion) in MS. The main findings were the development of a novel reproducible non-invasive measurement of perfusion and the demonstration that cord atrophy occurs early in MS and is progressive. Six first author papers published in peer reviewed scientific journals. Invited book chapters and reviews: W Rashid, A Cox, K Jackson, E McFadden, H Merriman, K Vernon. Symptomatic management of multiple sclerosis in primary care. Vol 51: R Nicholas, W Rashid. Multiple Sclerosis. Am Fam Physician 2013; 87: R Nicholas, W Rashid. Multiple Sclerosis. Clin Evid (Online) R Trimble, W Rashid. Rheumatoid, Sjogren s and other autoimmune diseases affecting the CNS. Joint Neurosciences Council 2011(ENS, EFNS, UCL) elearning module, Ebrain W Rashid, DT Chard, DH Miller. Atrophy. In: MRI aspects of neurodegeneration in MS. Eds: M Filippi, G Comi. Pub: Springer, Italia Invited book chapters and reviews (cont): W Rashid, DH Miller. Recent advances in neuroimaging of MS. In: Semin Neurol. 2008; 28: W Rashid. Film: Carandiru (review). BMJ 2004; 328: W Rashid, DH Miller. Perfusion MRI. In: The New Frontiers of MR-based Techniques in Multiple Sclerosis. Eds: M Filippi, G Comi. Pub: Springer-Verlag, Italia. 2003: Published papers and case reports: First Author: W Rashid, A Hadjiprocopis, GR Davies, CM Griffin, DT Chard, M Tiberio, DR Altmann, C Wheeler- Kingshott, D Tozer, AJ Thompson, DH Miller. Longitudinal evaluation of clinically early relapsingremitting multiple sclerosis with diffusion tensor imaging. J Neurol 2008; 255: W Rashid, GR Davies, DT Chard, CM Griffin, DR Altmann, AJ Thompson, DH Miller. Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing- 7/6/17 European Union, Page 3 / 7

4 remitting multiple sclerosis: a two year longitudinal study. Mult Scler 2007; 13: W Rashid, GR Davies, DT Chard, CM Griffin, DR Altmann, R Gordon, AJ Thompson, DH Miller. Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a three year study. J Neurol Neurosurg Psychiatry 2006; 77: W Rashid, GR Davies, DT Chard, CM Griffin, DR Altmann, R Gordon, R Kapoor, AJ Thompson, DH Miller. Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross sectional study of factors influencing cord size. J Magn Reson Imaging 2006; 23: W Rashid, LM Parkes, GT Ingle, DT Chard, AT Toosy, DR Altmann, MR Symms, PS Tofts, AJ Thompson, DH Miller. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: W Rashid, A Hadjiprocopis, CM Griffin, DT Chard, GR Davies, GJ Barker, PS Tofts, AJ Thompson, DH Miller. Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction. Mult Scler 2004; 10: Non-first author papers: K Papadopoulos, DJ Tozer, L Fisniku, DR Altmann, G Davies, W Rashid, AJ Thompson, DH Miller, DT Chard. T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis. Mult Scler 2010; 16: Published papers and case reports (cont): Non-first author papers (cont): B Audoin, G Davies, W Rashid, L Fisinku, A Thompson, D Miller. Voxel-based analysis of grey matter magnetisation transfer ratio maps in early relapsing-remitting multiple sclerosis. Mult Scler 2007; 13: GR Davies, A Hadjiprocopis, DR Altmann, DT Chard, CM Griffin, W Rashid, GJ Parker, PS Tofts, R Kapoor, AJ Thompson, DH Miller. Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. Mult Scler 2007; 13: VM Anderson, KT Fernando, GR Davies, W Rashid, C Frost, NC Fox, DH Miller. Cerebral atrophy measurement in clinically isolated syndromes and relapsing-remitting multiple sclerosis: a comparison of registration-based methods. J Neuroimaging 2007; 17: M Bieniek, DR Altmann, GR Davies, GT Ingle, W Rashid, J Sastre-Garriga, AJ Thompson, DH Miller. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: M Tiberio, DT Chard, DR Altmann, G Davies, CM Griffin, MA McLean, W Rashid, J Sastre-Garriga, AJ Thompson, DH Miller. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study. J Neurol 2006; 253: VD Karrenbauer, V Leoni, ET Lim, G Giovannoni, GT Ingle, J Sastre-Garriga, AJ Thompson, W Rashid, G Davies, DH Miller, I Bjorkhem, T Masterman. Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. Clin Neurol Neurosurg 2006; 108: A Hadjiprocopis, W Rashid, PS Tofts. Unbiased segmentation of diffusion weighted Magnetic Resonance Images of the brain using iterative clustering. Magn Reson Imaging 2005; 23: GR Davies, DR Altmann, W Rashid, DT Chard, CM Griffin, PS Tofts, GR Barker, R Kapoor, AJ Thompson, DH Miller. Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis. Mult Scler 2005; 11: GR Davies, DR Altmann, A Hadjiprocopis, W Rashid, DT Chard, CM Griffin, PS Tofts, GJ Barker, R Kapoor, AJ Thompson, DH Miller. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005; 252: Published papers and case reports (cont): Non-first author papers (cont): M Tiberio, DT Chard, DR Altmann, G Davies, CM Griffin, W Rashid, J Sastre-Garriga, AJ Thompson, DH Miller. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 2005; 64: DT Chard, CM Griffin, W Rashid, GR Davies, DR Altmann, R Kapoor, GJ Barker, AJ Thompson, DH Miller. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Mult Scler 2004; 10: GR Davies, L Ramió-Torrentà, A Hadjiprocopis, DT Chard, CMB Griffin, W Rashid, GJ Barker, AJ Thompson, DH Miller. Evidence for grey matter MTR abnormality in relapsing-remitting MS in patients with a short disease duration and minimal disability. J Neurol Neurosurg Psychiatry 2004; 75: 998-7/6/17 European Union, Page 4 / 7

5 1002. LM Parkes, W Rashid, DT Chard, PS Tofts. Normal cerebral perfusion measurements using ASL: Reproducibility, age and gender effects. Magn Reson Med 2004; 51: MA Abbas, R Cotta, W Rashid. Recurrent orogenital ulcers with papilloedema and headaches. Postgrad Med J 2002; 78(915): 54, Platform presentations at international conferences: ISMRM 3rd workshop of the White Matter Study Group: MR technology to assess pathology in-vivo. San Servolo, Venice, Italy, 9-11/10/03. What we have learned from the application of perfusion. Magnetic Resonance Techniques in Multiple Sclerosis, 6th Advanced Course. The potential of new MR based techniques to assess MS. Milan, Italy, 31/5-1/6/02. Perfusion MRI. International Workshop on the Normal Appearing Brain Tissue in Multiple Sclerosis. Institute of Neurology, London, UK, 6-7/12/01. Perfusion MRI: Early experiences in multiple sclerosis and normal control subjects. Platform presentations at national conferences: Neurology in Focus Future role of injectables in multiple sclerosis. CHARMS specialist multiple sclerosis nursing annual conference, Birmingham. September Specialist nurses in the new NHS. Improving patient pathways in multiple sclerosis, London. June Chairing the whole conference. Platform presentations at national conferences (cont): Neurology in Focus II, London. May The changing landscape for drugs in MS. Multiple Sclerosis 2011, London. December How can we improve the diagnostic process is early diagnosis important? Neurology in Focus, London. September Early treatment and intervention in MS. Presentations at regional meetings: I have spoken regularly at regional neuroscience meetings chiefly relating to topics on multiple sclerosis. These include the Kent, Surrey and Sussex neuroscience teaching days, regional neurology courses for general practitioners and talks to patient groups and the Multiple Sclerosis Society. Further over the past two years I have regularly presented to PCT/commissioning groups and on behalf of the regional strategic clinical network regarding service redesign and development for multiple sclerosis in the region. In addition from 2010 I have organised with industry support regular MS study evenings per year within Sussex open to all health professionals involved in the care of multiple sclerosis and to those people involved in commissioning services. The last meeting was in December Approximately 30 people have attended each meeting and it has received extremely positive feedback in the past. Audit presentations: Knowledge of DVLA guidelines amongst neurologists and non-neurologists (2006). Poster presentation at SENA meeting, Southampton 2006 and ABN Spring Meeting Cambridge Comparison of success and pain outcomes using bevelled and atraumatic lumbar puncture needles at City Hospital, Birmingham Presentation, treatment and follow-up of patients with Parkinsonism at City Hospital, Birmingham Intercalated BSc at the Wellcome Institute, University of London. The History of Medicine. Research Project: Dr Henry Vandyke Carter: The Link between Indian and Norwegian Leprosy in the Nineteenth Century. Historically detailing the career of a physician who (uniquely) actively participated in leprosy management in both countries and examining how management of this condition in two very different countries had important wider political and cultural implications. Projects Memberships General Medical Council ( ) Member of the Royal College of Physicians 7/6/17 European Union, Page 5 / 7

6 Association of British Neurologists (ABN) ABN neuroinflammatory disorders national committee London Multiple Sclerosis Group Royal Society of Medicine Medical Protection Society Other Relevant Information Managerial roles: Member of the Association of British Neurologists (ABN) national neuroinflammatory disorders committee. Responsible in conjunction with colleagues in forming policy, liaison with industry and government organisations (e.g. NICE) and other varied duties related to neuroinflammatory disease management in the United Kingdom. As part of this I have been involved in NICE scoping meetings and technical appraisals, formulated quality standards for MS care, advised on ABN policy to issues relating to MS and currently as part of the committee developing new treatment guidelines for the use of disease modifying therapies in MS. Member of the National Neurology Intelligence Network Neurology Expert Review Group. Chaired by Dr David Bateman appointed in February Neurological Long Term Conditions Clinical Lead for the South East Coast Strategic Clinical Network. Appointed from competitive interview on 3/2/14 with brief to develop new innovative pathways of care for neurological long term conditions, implement relevant NHS England service specifications and advise regional CCGs on how neurological care could be improved. Member of South East Coast Strategic Clinical Network Mental Health, Dementia and Neurological Conditions Steering Group and Neurology Clinical Advisory Group. Appointed to both committees in October Developing treatment pathways and guidelines for Kent, Surrey and Sussex to implement NHS England service specifications and advise regional CCGs. Neuroinflammatory disorders clinical lead for Sussex Since 2010 I have developed a tertiary referral specialist service for neuroinflammatory disorders liaising with trust management, commissioners and service users and have developed specialist clinics, new pathways of care, implementing NICE technical appraisals and advise, develop and mentor eight regional specialist MS nurses. Medical advisor to the Multiple Sclerosis Society Regularly assist the society in developing guidelines and policy decsions and response to NICE technical appraisals. Member of the James Lind Alliance priority setting partnership steering group Identified top ten prioritisation of research needs for people with MS in Clinical Supervisor to a clinical research registrar (Dr Jamie Campbell) undertaking a MD at the University of Sussex MD project investigating cognitive deficits secondary to multiple sclerosis and how cognitive rehabilitation may influence cognitive outcome and pathophysiology. Principle investigator several multiple sclerosis clinical trials Since 2010 working with a number of pharmaceutical companies providing the opportunity for people with MS regionally to potentially access new therapies for their condition. Career development: I was appointed to a substantive consultant post on the 24th November 2008 at the regional neuroscience centre for Sussex. I see myself as hard-working and progressive in my outlook. I believe that by fostering good relationships with fellow professionals you can reap rewards. I recognise the importance of planning for the future and looking at different ways to promote service enhancement and responsiveness. From this I have in what I believe to be a short space of time developed a comprehensive regional specialist service in multiple sclerosis that has proved popular with people with the condition and also has been cost effective. I feel one of my strengths is with working with fellow professionals and achieving shared goals. I am diligent and driven but also personable and enjoy all aspects of my life. 7/6/17 European Union, Page 6 / 7

7 7/6/17 European Union, Page 7 / 7